Free. Unsubscribe any time.
Xeris Biopharma Holdings, Inc. (XERS)
Xeris Biopharma Holdings, Inc. filed 27 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 9 reporting owners, covering 29 transactions and 529,317 shares. None carries the SEC's AFF10B5ONE flag; all 27 name a plan in a footnote. 9 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-01, came on the same day as the one before it (2026-09-01) and reports 1 transaction against 1 in the filing before it.
- The sales it reports total 15,000 shares, 10,000 more than the 5,000 in the filing before it.
- Of the 10 companies the register lists beside it in its industry, 3 have more plan statements on file than it and 7 have fewer.
- Its 27 filings on file run from 2025-09-12 to 2026-09-01, and state 6 plan adoption dates, from 2025-06-12 to 2025-09-12.
Trades in Xeris Biopharma Holdings, Inc. 29
- PERSKY MARLA — 2025-09-11 · S · 15,500 shares
- Hecht Beth — 2025-11-11 · S · 16,667 shares
- Shannon John Patrick Jr — 2025-11-13 · S · 23,242 shares
- Hecht Beth — 2025-12-01 · S · 16,667 shares
- BORMANN-KENNEDY BARBARA-JEAN ANNE — 2025-12-12 · S · 15,000 shares
- Hecht Beth — 2026-01-02 · S · 16,667 shares
- Shannon John Patrick Jr — 2026-01-05 · S · 24,907 shares
- McCulloch Kevin — 2026-01-08 · S · 15,000 shares
- Hecht Beth — 2026-02-02 · S · 16,667 shares
- Hecht Beth — 2026-03-02 · S · 16,567 shares
- Hecht Beth — 2026-03-02 · S · 100 shares
- Brady James Aloysius — 2026-03-30 · S · 10,834 shares
Adoption dates in Xeris Biopharma Holdings, Inc. 6
- 2025-06-12 — stated in 1 filing
- 2025-08-08 — stated in 3 filings
- 2025-08-13 — stated in 1 filing
- 2025-08-18 — stated in 3 filings
- 2025-09-04 — stated in 4 filings
- 2025-09-12 — stated in 1 filing
Results prints in Xeris Biopharma Holdings, Inc. 9
- 2025-01-10
- 2025-03-06
- 2025-05-08
- 2025-08-07
- 2025-11-06
- 2026-01-08
- 2026-03-02
- 2026-05-07
- 2026-08-06
Trades before a print in Xeris Biopharma Holdings, Inc. 6
- 0 days before the 2026-01-08 print — 2026-01-08 · S · McCulloch Kevin · 15,000 shares
- 0 days before the 2026-03-02 print — 2026-03-02 · S · Hecht Beth · 16,567 shares
- 0 days before the 2026-03-02 print — 2026-03-02 · S · Hecht Beth · 100 shares
- 3 days before the 2026-01-08 print — 2026-01-05 · S · Shannon John Patrick Jr · 24,907 shares
- 3 days before the 2026-08-06 print — 2026-08-03 · S · Hecht Beth · 16,666 shares
- 3 days before the 2026-08-06 print — 2026-08-03 · S · McCulloch Kevin · 15,000 shares
- 6 days before the 2026-01-08 print — 2026-01-02 · S · Hecht Beth · 16,667 shares
- 6 days before the 2026-05-07 print — 2026-05-01 · S · Hecht Beth · 16,667 shares
- 27 days before the 2026-01-08 print — 2025-12-12 · S · BORMANN-KENNEDY BARBARA-JEAN ANNE · 15,000 shares
- 28 days before the 2026-03-02 print — 2026-02-02 · S · Hecht Beth · 16,667 shares
- 30 days before the 2026-08-06 print — 2026-07-07 · S · Pieper Steven · 27,600 shares
- 31 days before the 2026-08-06 print — 2026-07-06 · S · Pieper Steven · 17,400 shares
Interval to Xeris Biopharma Holdings, Inc.’s next reported results date
How the interval and sources are counted →
- 6within 5 days
- 8within 10 days
- 0shortest, days
- 4no later print
- Hecht Beth 2026-01-02 · S · 6 days before the 2026-01-08 print · See Remarks
- Shannon John Patrick Jr 2026-01-05 · S · 3 days before the 2026-01-08 print · See Remarks
- McCulloch Kevin 2026-01-08 · S · 0 days before the 2026-01-08 print · See Remarks
- Hecht Beth 2026-03-02 · S · 0 days before the 2026-03-02 print · See Remarks
- Hecht Beth 2026-03-02 · S · 0 days before the 2026-03-02 print · See Remarks
- Hecht Beth 2026-05-01 · S · 6 days before the 2026-05-07 print · See Remarks
- Hecht Beth 2026-08-03 · S · 3 days before the 2026-08-06 print · See Remarks
- McCulloch Kevin 2026-08-03 · S · 3 days before the 2026-08-06 print · See Remarks
Adoption dates Xeris Biopharma Holdings, Inc. states
- 2025-06-12 in 1 filing
- 2025-08-08 in 3 filings
- 2025-08-13 in 1 filing
- 2025-08-18 in 3 filings
- 2025-09-04 in 4 filings
- 2025-09-12 in 1 filing
Filing text: “10b5-1 trading plan adopted by the reporting person on August 13, 2025”
Reported results dates on file
- 2025-01-10
- 2025-03-06
- 2025-05-08
- 2025-08-07
- 2025-11-06
- 2026-01-08
- 2026-03-02
- 2026-05-07
- 2026-08-06
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.